wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-48124829-3FA4-45D4-96A9-2FC06A91E25C
Q38404422-48124829-3FA4-45D4-96A9-2FC06A91E25C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-48124829-3FA4-45D4-96A9-2FC06A91E25C
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-48124829-3FA4-45D4-96A9-2FC06A91E25C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-48124829-3FA4-45D4-96A9-2FC06A91E25C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.